New combo therapy aims to control liver cancer without surgery
NCT ID NCT06040099
First seen Nov 06, 2025 · Last updated May 10, 2026 · Updated 22 times
Summary
This study tests whether a two-drug immunotherapy combination (durvalumab and bevacizumab) given after a precise internal radiation treatment (TARE) can help control liver cancer that cannot be removed by surgery. About 58 adults with this type of liver cancer will receive the radiation first, then the drugs. The main goal is to see how long the cancer stays under control and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Aurora, Colorado, 80045, United States
-
Research Site
Gainesville, Florida, 32608, United States
-
Research Site
Orlando, Florida, 32804, United States
-
Research Site
Atlanta, Georgia, 30322, United States
-
Research Site
Atlanta, Georgia, 30342, United States
-
Research Site
Chicago, Illinois, 60611, United States
-
Research Site
Boston, Massachusetts, 02118, United States
-
Research Site
Detroit, Michigan, 48201, United States
-
Research Site
St Louis, Missouri, 63110, United States
-
Research Site
Trenton, New Jersey, 08690, United States
-
Research Site
Buffalo, New York, 14263, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
Chapel Hill, North Carolina, 27599, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Portland, Oregon, 97239, United States
-
Research Site
Philadelphia, Pennsylvania, 19107, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Charlottesville, Virginia, 22908, United States
-
Research Site
Seattle, Washington, 98195, United States
-
Research Site
Milwaukee, Wisconsin, 53215, United States
-
Research Site
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.